tiprankstipranks
Trending News
More News >
Akebia Therapeutics (AKBA)
NASDAQ:AKBA

Compare Akebia Therapeutics (AKBA) vs. Competitors

Compare
1,587 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Akebia Therapeutics
$1.36
$360.90M
-17.87
-29.53%
3 Buy
0 Hold
0 Sell
Strong Buy
Oruka Therapeutics
$33.40
$1.62B
-13.82
165.08%
11 Buy
0 Hold
0 Sell
Strong Buy
Theravance Biopharma
$20.01
$1.01B
35.57
137.09%
4 Buy
1 Hold
0 Sell
Strong Buy
Vir Biotechnology
$6.06
$843.10M
-1.67
-39.70%
8 Buy
0 Hold
0 Sell
Strong Buy
ProKidney
$2.29
$688.91M
-4.21
38.79%
1 Buy
1 Hold
1 Sell
Hold
ArriVent BioPharma, Inc.
$20.86
$861.13M
-4.93
-14.79%
11 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
AKBA
Akebia Therapeutics
1.36
-1.01
-42.62%
ORKA
Oruka Therapeutics
33.40
20.42
157.32%
TBPH
Theravance Biopharma
20.01
10.86
118.69%
VIR
Vir Biotechnology
6.06
-4.36
-41.84%
PROK
ProKidney
2.29
0.50
27.93%
AVBP
ArriVent BioPharma, Inc.
20.86
-4.45
-17.58%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts